Notice of extraordinary general meeting in SURGICAL SCIENCE SWEDEN AB (publ)

Summary by AI BETAClose X

Surgical Science has convened an extraordinary general meeting on 11 December 2026 to request authorisation for the board to acquire and transfer up to 10% of outstanding shares (51,026,236 shares outstanding; up to approximately 5,102,624 shares) until the next annual general meeting, with purchases on Nasdaq First North Growth Market at market-limited prices and cash payment, transfers permitted on-market or by set-off or in kind, and the proposal requiring a qualified two-thirds majority; record date is 3 December 2026 and notice/advance-vote deadline is 7 December 2026.

Disclaimer*

UK 100

Latest directors dealings